Program Spending to Increase Adherence: South African Cervical Cancer Screening

Background Adherence is crucial for public health program effectiveness, though the benefits of increasing adherence must ultimately be weighed against the associated costs. We sought to determine the relationship between investment in community health worker (CHW) home visits and increased attendance at cervical cancer screening appointments in Cape Town, South Africa. Methodology/Principal Findings We conducted an observational study of 5,258 CHW home visits made in 2003–4 as part of a community-based screening program. We estimated the functional relationship between spending on these visits and increased appointment attendance (adherence). Increased adherence was noted after each subsequent CHW visit. The costs of making the CHW visits was based on resource use including both personnel time and vehicle-related expenses valued in 2004 Rand. The CHW program cost R194,018, with 1,576 additional appointments attended. Adherence increased from 74% to 90%; 55% to 87%; 48% to 77%; and 56% to 80% for 6-, 12-, 24-, and 36-month appointments. Average per-woman costs increased by R14–R47. The majority of this increase occurred with the first 2 CHW visits (90%, 83%, 74%, and 77%; additional cost: R12–R26). Conclusions/Significance We found that study data can be used for program planning, identifying spending levels that achieve adherence targets given budgetary constraints. The results, derived from a single disease program, are retrospective, and should be prospectively replicated.

[1]  M. Stirratt,et al.  Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research , 2008, Current HIV/AIDS reports.

[2]  J. Franks,et al.  Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  K. Abba,et al.  Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. , 2008, The Cochrane database of systematic reviews.

[4]  Vikram Patel,et al.  Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care , 2008, The Lancet.

[5]  X. Castellsagué,et al.  An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. , 2008, Vaccine.

[6]  D. van Rensburg,et al.  Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. , 2008, Health policy and planning.

[7]  S. van Dulmen,et al.  Patient adherence to medical treatment: a review of reviews , 2007, BMC Health Services Research.

[8]  L. Denny Cervical Cancer: The South African Perspective , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  J. Dillner,et al.  Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. , 2006, Vaccine.

[10]  Michael Quinn,et al.  Chapter 8: Screening for cervical cancer in developing countries. , 2006, Vaccine.

[11]  F. Bray,et al.  Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.

[12]  J. T. Cox,et al.  Chapter 7: Achievements and limitations of cervical cytology screening. , 2006, Vaccine.

[13]  D. Harper,et al.  Chapter 13: Current findings from prophylactic HPV vaccine trials. , 2006, Vaccine.

[14]  Sue J Goldie,et al.  Cost-effectiveness of cervical-cancer screening in five developing countries. , 2005, The New England journal of medicine.

[15]  Thomas C Wright,et al.  Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. , 2005, JAMA.

[16]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[17]  Irina Cleemput,et al.  Economic implications of non-compliance in health care , 2002, The Lancet.

[18]  T. Wright,et al.  Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.

[19]  P. Garner,et al.  Interventions for promoting adherence to tuberculosis management. , 2000, The Cochrane database of systematic reviews.

[20]  J. Mandelblatt,et al.  Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. , 2000, Preventive medicine.

[21]  Judith A. Hall,et al.  Effectiveness of interventions to improve patient compliance: a meta-analysis. , 1998, Medical care.

[22]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[23]  D. Harper,et al.  Current findings from prophylactic HPV vaccine trials , 2006 .

[24]  L. Denny Cervical cancer: the South African perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[25]  F. Bray,et al.  The burden of HPV-related cancers , 2006 .

[26]  J. Singh Clinical Trial Results , 2006 .

[27]  E. Denny,et al.  Cost Effectiveness and Resource Allocation Open Access the Costs of Reducing Loss to Follow-up in South African Cervical Cancer Screening , 2005 .

[28]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.